Rederm ointment 15g tube

$5.13

Rederm ointment 15g tube

Quantity:

SKU: 0641860462 Categories: , , Tags: ,

Description

Composition
Active substance:
100 g of ointment contains: Betamethasone dipropionate Betamethasone based on – 0.05g, salicylic acid – 3.0 g ;.
Excipients:
Liquid paraffin (paraffin oil), petroleum jelly (white petrolatum, white soft paraffin).
Description:
Almost white, translucent, homogeneous ointment.
Product form:
Ointment for external use.
5 g, 15 g or 30 g aluminum tubes. Each tube together with instructions for use placed in a pile of cardboard.
Contraindications
Children under 2 years of age, lactation, hypersensitivity, open wounds, bacterial, viral and fungal skin diseases (pyoderma, syphilis, tuberculosis skin, chicken pox, herpes, actinomycosis, blastomycosis, sporotrichosis); postvaccinal skin reactions, perioral dermatitis, rosacea, trophic ulcers with chronic venous insufficiency, skin tumors (cancer of the skin, nevi, atheroma, epithelioma, melanoma, hemangioma, xanthoma, sarcoma).
Carefully
Hepatic failure, children’s age (older than 2 years), long-term therapy, especially with the use of occlusive dressings.
Indications
Rederm indicated for use in the treatment of subacute and chronic dermatoses accompanied by hyperkeratosis and desquamation: psoriasis, disgidrotichesky dermatitis, eczema, atopic dermatitis, lichen planus, ichthyosis and ichthyotic skin lesions, atopic dermatitis, atopic eczema; simple and allergic dermatitis; urticaria, erythema multiforme; simple chronic zoster (restricted neurodermatitis). Dermatoses, not amenable to treatment with other glucocorticosteroids (especially red warty zoster), skin dyshydrosis.
Interaction with other drugs
Drug interactions with other drugs is not revealed.
Overdose
Acute overdose is highly unlikely, however, when excessive or prolonged application of the drug overdose, chronic possible, accompanied by signs of Cushing: hyperglycemia, glycosuria, reversible depression of adrenocortical function, a manifestation of Cushing’s syndrome.
Treatment. Displaying appropriate symptomatic treatment. In the case of chronic toxic recommended a gradual withdrawal of the drug.
pharmachologic effect
Pharmacological group:
Glucocorticosteroid + topical keratolytic agent.
Pharmacological properties:
Combined preparation for external use, the action of which is due to its constituent components; the drug has anti-inflammatory, antiallergic, antipruritic, keratolytic action. Betamethasone inhibits the release of mediators of inflammation, prevents accumulation of neutrophils boundary, reduces the inflammatory exudate and cytokine production, reduce the migration of macrophages, resulting in a reduction of infiltration and granulation processes.
Due to the presence of salicylic acid softens the skin, removes horny layers and promotes deeper penetration betamethasone.
Pregnancy and breast-feeding
Safety of the use of local glucocorticosteroids has not been established in pregnant women. The purpose of this group of drugs in pregnancy is justified only if the potential benefit to the mother outweighs the potential risk to the fetus. During pregnancy, this group of drugs should not be used in high doses or for long periods.
It not determined whether the topical application of glucocorticosteroids cause the appearance of their mother’s milk, so you should resolve the issue of termination of breastfeeding.
Conditions of supply of pharmacies
Without a prescription.
side effects
Burning, irritation, dryness, hypopigmentation, skin itching, folliculitis, hypertrichosis, dermatitis, rashes aknepodobnye.
In the application of occlusive dressings – maceration of the skin, striae, skin atrophy, secondary infection, sudamen.
With prolonged use – skin atrophy, local hirsutism, telangiectasia, purpura, hypopigmentation, hypertrichosis.
When applied to the large surfaces – systemic manifestation of side effects of glucocorticoids (stunting, Cushing’s syndrome, intracranial hypertension after treatment, hyperglycemia, glycosuria, hypokalemia, increased blood pressure) or salicylates (pallor, fatigue, drowsiness, hyperventilation on the background tachypnea, nausea, vomiting, hearing loss, mental confusion).
special instructions
Children from 2 years of drug prescribed only under strict indications and under medical supervision, as may develop systemic side effects related to betamethasone. The duration of treatment should be as short as possible. In applying the drug on extensive surfaces and / or under an occlusive dressing is possible to suppress the hypothalamic-pituitary-adrenal system and the development of Cushing’s symptoms can be observed decrease in excretion of growth hormone, increased intracranial pressure.
Avoid the drug in the eye, can not be applied to the skin near the eyes and mucous membranes. The drug is not intended for use in ophthalmology.
For prolonged treatment, when applied to the preparation extensive skin surface when using occlusive dressings available glucocorticoids systemic absorption.
We do not recommend long-term use on the skin of the face – may develop dermatitis on rosacea type, perioral dermatitis, skin atrophy and acne; Avoid use in the anogenital region.
Ointment is most suitable for the treatment of patients with dry and fragile skin.
If signs of hypersensitivity or skin irritation associated with the use of the drug, should discontinue treatment and patient choose the adequate therapy.
With long-term use of the drug its abolition should be carried out gradually.
Storage conditions
The reach of children at a temperature not higher than 25 ° C.
Dosing and Administration
Outwardly. Apply to the affected area from the calculation: ointments column length of 0.5 cm at the skin site size of about 7 cm? 7 cm, gently rubbing a thin layer 2 times a day. Another application frequency can be set to a doctor, on the basis of the severity of disease. In mild cases enough to apply the ointment, as a rule, once a day; in more severe injuries may require more frequent application.
If necessary occlusive bandage is applied, and are changed every 24 hours.
The duration of treatment depends on the efficacy and tolerability of the therapy and is 2-4 weeks.
If clinical improvement does not occur, it is necessary to specify the diagnosis.
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist

Additional information

Weight0.100 kg
Manufacturer

VERTEX

There are no reviews yet.

Add your review